Skip to main content
SpringerLink
Log in

Medication Adherence After Myocardial Infarction: A Long Way Left To Go

  • Editorial
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746–53.

    Article  PubMed  CAS  Google Scholar 

  2. Yach D, Leeder S, Bell J, Kistnasamy B. Global chronic diseases. Science. 2005;307(5708):317.

    Article  PubMed  CAS  Google Scholar 

  3. American Heart Association. Heart Disease and Stroke Statistics—2006 Uptake. Dallas: American Heart Association; 2004.

  4. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:E1–E211.

    Article  PubMed  Google Scholar 

  5. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.

    Article  PubMed  CAS  Google Scholar 

  6. Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz HM. A qualitative study of increasing beta-blocker use after myocardial infarction: Why do some hospitals succeed? JAMA. 2001;285:2604–11.

    Article  PubMed  CAS  Google Scholar 

  7. American Heart Association. Get With The Guidelines. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3045578. Accessed July 10, 2007.

  8. Rogers AM, Ramanath VS, Grzybowski M, et al.. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: The American College of Cardiology’s Guidelines Applied in Practice (GAP) initiative in Michigan. Am Heart J. 2007;154:461–9.

    Article  PubMed  Google Scholar 

  9. Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004. N Engl J Med. 2005;353:255–64.

    Article  PubMed  CAS  Google Scholar 

  10. [No authors listed] A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982;247(12):1707–1714 (Mar 26).

  11. Lee TH. Eulogy for a quality measure. N Engl J Med. 2007;357:1175–7.

    Article  PubMed  CAS  Google Scholar 

  12. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.

    Article  PubMed  Google Scholar 

  13. Ackincigil A, Bowblis JR, Levin C, Jan S, Patel M, Crystal S. Long-term adherence to evidence-based secondary prevention therapies after acute myocardial infarction. J Gen Intern Med. 2008 (in press). DOI 10.1007/s11606-007-0351-9.

  14. World Health Organization. Adherence to long-term therapies: Evidence for action. Available at: www.who.int/chronic_conditions/en/adherence_report.pdf. Accessed January 6, 2006.

  15. Kramer JM, Hammill B, Anstrom PJ, et al. National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J. 2006;152:454.e451–454.e458.

    Article  Google Scholar 

  16. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455–61.

    Article  PubMed  Google Scholar 

  17. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–12.

    Article  PubMed  CAS  Google Scholar 

  18. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002;88:229–33.

    Article  PubMed  CAS  Google Scholar 

  19. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842–7.

    Article  PubMed  Google Scholar 

  20. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–86.

    Article  PubMed  CAS  Google Scholar 

  21. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331–6.

    Article  PubMed  Google Scholar 

  22. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.

    Article  PubMed  CAS  Google Scholar 

  23. Sokol MC, McGuigan KA, Verbrugge R, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–30.

    Article  PubMed  Google Scholar 

  24. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167:540–9.

    Article  PubMed  Google Scholar 

  25. Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. The cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2007 (in press).

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Niteesh K. Choudhry MD, PhD & Wolfgang C. Winkelmayer MD, ScD

  2. Renal Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Wolfgang C. Winkelmayer MD, ScD

Authors
  1. Niteesh K. Choudhry MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang C. Winkelmayer MD, ScD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niteesh K. Choudhry MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choudhry, N.K., Winkelmayer, W.C. Medication Adherence After Myocardial Infarction: A Long Way Left To Go. J GEN INTERN MED 23, 216–218 (2008). https://doi.org/10.1007/s11606-007-0478-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-007-0478-8

Search

Navigation